5 years after diagnosis I'm still struggling to correlate the information about the exon-to-be-skipped, and the out-of-frame deletion my son has.
Can anybody help? Boils down to this:
My son has out-of-frame deletion at exon 17. Does this make him a candidate for this GSK trial which skips exon 51? I've seen some information that suggests "yes" other that says "no."
Any feedback is welcome.